TI
ODT

Trexquant Investment’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Trexquant Investment’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-30,165
Closed -$425K – 1421
2018
Q4 		$425K Buy
+30,165
New +$470K 0.03% 668

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Trexquant Investment's ODT Position: Q1 2019 in Review

Trexquant Investment sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q1 2019, closing a stake of 30,165 shares — an estimated $425K sold.

Trexquant Investment first reported a position in ODT in Q4 2018 and held it in 1 quarter. The position peaked at $425K in Q4 2018. 57 funds tracked by Wall St. Rank hold ODT as of Q1 2019.

  • Trexquant Investment reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 30,165 Odonate Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $425K.
  • Trexquant Investment first reported a position in Odonate Therapeutics, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Trexquant Investment's Odonate Therapeutics, Inc. Common Stock position peaked at $425K in Q4 2018.
  • 57 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.